Vicebio Revenue

Biotechnology Research • United Kingdom • 21-50 Employees

Vicebio revenue & valuation

Annual revenue	$1,882,210
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$6,100,000
Total funding	$100,000,000

Key Contact at Vicebio

Elisabeth De Brouwer

Associate Corporate Director

Company overview

Headquarters	United Kingdom
Website	vicebio.com
NAICS	541714
Keywords	Vaccines, Influenza, RSV, Parainfluenza, Sars-Cov-2, Metapneumovirus, Structural Vaccinology, Respiratory Viruses
Founded	2019
Employees	21-50
Socials

Vicebio Email Formats

Vicebio uses 3 email formats. The most common is {first initial} (e.g., j@vicebio.com), used 69.2% of the time.

Format	Example	Percentage
{first initial}	j@vicebio.com	69.2%
{first name}.{last name}	john.doe@vicebio.com	23.1%
	@vicebio.com	7.7%

About Vicebio

Vicebio is a clinical-stage biopharmaceutical company developing transformative multi-pathogen vaccines for respiratory viral infections. At the core of our work is Vicebio’s groundbreaking Molecular Clamp Technology, which locks viral proteins in their optimal conformation. This innovation enables our vaccines to deliver a unique combination of broad protection, ready-to-use administration, and convenient manufacturing. Our lead program is a best-in-class multivalent vaccine targeting five respiratory diseases, positioning Vicebio as a leader in multipathogen respiratory vaccines.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

Manager

C-Suite

Employees by Department

Vicebio has 9 employees across 6 departments.

Departments

Number of employees

Funding Data

Explore Vicebio's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2024-10-23	5	$100,000,000

Funding Insights

$100,000,000

Total funding amount

$100,000,000

Most recent funding amount

Number of funding rounds

Frequently asked questions

Vicebio is located in GB.

Vicebio generates an estimated annual revenue of $1,882,210. This revenue figure reflects the company's market position and business performance in its industry.

Vicebio has an estimated valuation of $6,100,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Vicebio was founded in 2019, making it 7 years old. The company has established itself as a significant player in its industry over this time.

Vicebio has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Vicebio has raised a total of $100,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Vicebio

Elisabeth De Brouwer

Associate Corporate Director

4.8

40,000 users